Evaluation of safety and effectiveness of liposomal hyaluronic acid, PRP and vitamin C in rejuvenation and brightening under the eyes
Phase 1
Recruiting
- Conditions
- Darkening under the eye.
- Registration Number
- IRCT20200127046282N28
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Darkness and wrinkles in the lower eyelid area, which need to be treated according to the opinion of the hospital doctor and the patient's desire.
Exclusion Criteria
Patients who had undergone previous surgery in the eyelid area
Have had previous minimally invasive treatments such as botulinum toxin or fillers in the eyelid area.
Patients with active skin disorders or inflammation, acute or chronic infection, tumors or cancer
Patients under anticoagulant treatment
smokers
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The amount of darkness under the eyes. Timepoint: prior to treatment, three and six months after the last treatment session. Method of measurement: VisioFace device.;The amount of wrinkles under the eyes. Timepoint: prior to treatment, three and six months after the last treatment session. Method of measurement: Visioface.
- Secondary Outcome Measures
Name Time Method Patient satisfaction. Timepoint: prior to treatment, three months and six months after the last treatment session. Method of measurement: Standard questionnaires visual analogue scale (VAS).